Methotrexate (MTX) has been a longstanding therapeutic option for mycosis fungoides (MF); however, data on its real‐world effectiveness remain limited. This study aimed to assess real‐world outcomes of oral MTX in the treatment of MF. Data from five referral centres for cutaneous lymphoma in Greece were retrospectively reviewed with the baseline‐ and ...
Vasiliki Nikolaou+21 more
wiley +1 more source
Scalp Involvement in Primary Cutaneous Lymphomas-An Update on Clinical Presentation, Diagnostics, and Management. [PDF]
Kołkowski K+5 more
europepmc +1 more source
Acneiform type of mogamulizumab‐associated rash
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Inga Hansen‐Abeck+5 more
wiley +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study. [PDF]
Huang L+36 more
europepmc +1 more source
Erythematous Macular Eruption in an Older Woman [PDF]
Kernohan, Neil+2 more
core +2 more sources
Erythema annulare centrifugum and Hodgkin lymphoma during pregnancy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Valentine Horiot+7 more
wiley +1 more source
Prognosis of increasing percentages of lesional body surface area in early stage mycosis fungoides
This study identifies a progressive decline in overall survival with each 10% increase in BSA in early‐stage mycosis fungoides. A new BSA cut‐off of 40% is proposed as a significant prognostic factor for patients with patch/plaque‐stage disease, with potential therapeutic consequences.
Juliette M. Kersten+8 more
wiley +1 more source
A case of angioimmunoblastic T-cell lymphoma mimicking angioedema. [PDF]
Zhao H, Xia Y, Su F, Chen L, Hu B.
europepmc +1 more source
Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance
When managing psoriasis, induced or exacerbated by ICI therapy for cancer, there are concerns regarding immunosuppression from systemic agents for the treatment of psoriasis and the potential impact on ICI efficacy. No direct, high‐level evidence exists to address these concerns.
Kim A. Papp+14 more
wiley +1 more source